Dinagul Baesheva

Dinagul Baesheva

Auto-generated profile, based on publicly available information

Dinagul Baesheva

Astana Medical University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2025 in Journal of Biological Research
Verified
Journal Article
Open access
PDF file
TITalgat Ibraev
Talgat Ibraev
GZGulmira Ablaevna Zhauarova
Gulmira Ablaevna Zhauarova
DBDinagul Baesheva
Dinagul Baesheva
Neonatal sepsis remains one of the leading causes of mortality among newborns, with Klebsiella pneumoniae being one of the most common etiological agents. This article presents the first successful case in Kazakhstan of hemofiltration use in a neonate with sepsis caused by Klebsiella pneumoniae ESBL 10⁷ CFU/ml. The case highlights the clinical characteristics, decision-making process, and effectiveness of prolonged veno-venous hemofiltration (PVVHF) as adjunctive therapy. Hemofiltration contributed to hemodynamic stabilization, correction of metabolic acidosis, reduction of inflammatory markers, and successful extubation, demonstrating the potential role of extracorporeal therapies in critically ill neonates.

31 July 2026 in Vaccines
Verified
Journal Article
Open access
PDF file
Yerke SuleimenovaYerke Suleimenova
Yerke Suleimenova
Indira KaribayevaIndira Karibayeva
Indira Karibayeva
Шнара СветлановаШнара Светланова
Шнара Светланова
Nurzhamal AkhmadyarNurzhamal Akhmadyar
Nurzhamal Akhmadyar
DBDinagul Bayesheva
Dinagul Bayesheva
ABAida Bolatbek
Aida Bolatbek
Background/Objectives: Rotavirus remains a major cause of acute gastroenteritis among children under five years of age, particularly in regions with heterogeneous vaccine implementation. In Central Asia, differences in the timing and coverage of rotavirus vaccination may influence circulating genotype patterns, yet regional evidence remains fragmented. Methods: A systematic review and meta-analysis were conducted in accordance with PRISMA 2020 guidelines and registered in PROSPERO (CRD420251274198). Electronic databases (PubMed, Web of Science, ScienceDirect, and Google Scholar) were searched without date restrictions. Studies reporting laboratory-confirmed rotavirus infection and genotype distribution among children under five years in Central Asia were included. Random-effects meta-analysis of proportions was performed to estimate the pooled genotype proportions among rotavirus-positive children, with subgroup analyses comparing the before and after vaccine introduction periods. Results: Six studies (ten before vaccine introduction strata and four after vaccine introduction strata; N = 1713 rotavirus-positive children) were included. A significant decline in the G1P[8] genotype was observed following vaccine introduction, with pooled prevalence decreasing from 0.468 (95% CI: 0.363–0.577) to 0.068 (95% CI: 0.034–0.133) (p < 0.001). In contrast, G2P[4] increased from 0.134 to 0.485 (p < 0.001), while G9P[4] and G9P[8] also increased significantly. G3P[8] and mixed genotypes declined, whereas G4P[8], G12P[8], and untypable strains showed no statistically significant subgroup differences. Substantial heterogeneity was observed (I2 > 90%), and evidence certainty was very low for all genotype outcomes. Conclusions: The available evidence suggests that rotavirus genotype distribution among children under five in Central Asia may have changed after vaccine introduction, with lower pooled proportions of G1P[8] and higher proportions of selected heterotypic genotypes in after vaccine introduction strata. Strengthened molecular surveillance using standardized genotyping protocols is needed to determine whether these patterns represent sustained genotype replacement or temporal fluctuation. These estimates are based on a small, heterogeneous evidence base with very low certainty and should be considered hypothesis-generating rather than confirmatory of a causal vaccine effect.

31 December 2022 in Vestnik
Verified
Journal Article
Closed access
ИДИ.с. Джаксыбаева
И.с. Джаксыбаева
РБР.з. Боранбаева
Р.з. Боранбаева
САС.т. Абдрахманова
С.т. Абдрахманова
РМР.с. Майтбасова
Р.с. Майтбасова
ПИП.к. Ишуова
П.к. Ишуова
НЖН.т. Жанузакова
Н.т. Жанузакова
Мультисистемный воспалительный синдром (МВС), ассоциированный с COVID-19, представляет собой тяжелое гипервоспалительное состояние у детей и подростков, связанное с предшествующей инфекцией SARS-CoV-2, характеризующееся лихорадкой, воспалением и мультисистемным поражением. Было проведено ретроспективное исследование у детей с МВС, ассоциированным с SARS-CoV-2, получавших стационарное лечение в многопрофильных детских медицинских организациях 17 регионов Казахстана c 1 августа 2020г. по 15 июня 2022г. Всего в исследование вошло 96 пациентов. У большинства пациентов наблюдались изменения в общем анализе крови, повышение маркеров воспаления. Половина детей нуждались в лечении отделение реанимации и интенсивной терапии (ОРИТ). Целью данного исследования является описание клинических проявлений и наиболее частых изменений в лабораторных показателях у детей с МВС, ассоциированным с SARS-CoV-2 в РК. COVID-19-мен ассоциирленген көп жүйелі қабыну синдромы (КҚС) – балалар мен жасөспірімдердегі SARS-CoV-2 инфекциясымен байланысты, қызбамен, қабынумен және көпжүйелі зақымданумен сипатталатын ауыр гиперқабыну жағдайы. 2020 жылдың 1- тамызынан бастап 2022 жылдың 15-маусымына дейін Қазақстанның 17 облысында көп бейінді балалар медициналық ұйымдарында стационарлық ем қабылдаған SARS-CoV-2-мен байланысты КҚС бар балаларға ретроспективті зерттеу жүргізілді. Зерттеуге барлығы 96 науқас қатысты. Пациенттердің көпшілігінде жалпы қан анализінде өзгерістер, қабыну маркерлерінің жоғарылауы байқалды. Балалардың жартысы жансақтау бөлімінде емделуді қажет етті. Multisystem inflammatory syndrome (MIS-С) associated with COVID-19 is a severe hyperinflammatory condition in children and adolescents associated with a previous SARS-CoV-2 infection, characterized by fever, inflammation and multisystem lesion. A retrospective study was conducted in children with MIS associated with SARS-CoV-2 who received inpatient treatment in multidisciplinary children's medical organizations in 17 regions of Kazakhstan from August 1, 2020 to June 15, 2022. A total of 96 patients were included in the study. The majority of patients had changes in the general blood test, increased markers of inflammation. Half of the children needed treatment in the intensive care unit (ICU). The purpose of this study is to describe the clinical manifestations and the most frequent changes in laboratory data in children with MVS associated with SARS-CoV-2 in the Republic of Kazakhstan.

30 April 2025 in Наука и здравоохранение
Verified
Journal Article
Open access
DBD.A. Baesheva
D.A. Baesheva
GZG.D. Zhumagalieva
G.D. Zhumagalieva
BKB.N. Kosherova
B.N. Kosherova
BTBayan Turdalina
Bayan Turdalina
AAA.V. Altynbekova
A.V. Altynbekova
ASAliya Seidullayeva
Aliya Seidullayeva
Relevance: Bacterial meningitis (BM) remains a significant cause of neurological complications and high mortality among children. Aim: to study the clinical features of BM in children to optimize the diagnosis and etiopathogenetic therapy. Methods: The object of the study is children diagnosed with meningitis, treated at the Multidisciplinary City Children's Hospital No. 3 in Astana, for the period from 2015 to 2023. Study design: prospective, control - case. Methods included clinical examination, complete blood count, cerebrospinal fluid test, CT and brain MRI. Descriptive statistics and Pearson's method were used for statistical processing. Results: Introduction of the PCV13 vaccine led to a fourfold decrease in the incidence of pneumococcal meningitis, while cases of meningococcal meningitis declined 1.6 times from 2014 to 2023. The main clinical manifestations in children with BM included high fever (80–90% of patients, with febrile temperatures ranging from 38.7°C to 39.9°C), neurological deficits, and complications: seizures and cognitive impairment developed in 50% of children. Hypertensive syndrome was observed in 81.8% of children with pneumococcal meningitis (PM), and in 55.6% of meningococcal meningitis (MM) cases among children under one year old. Pneumococcal CNS involvement was characterized by focal symptoms in 45.5% of young children, while such changes were statistically significantly lower in MM cases—threefold less (16.7%, p≤0.001). Spearman’s correlation analysis in the PM group showed a strong direct positive relationship between the following variables: delayed medical consultation and hospital stay duration (r=0.7; p≤0.001), delayed diagnosis and hospital stay duration (r=0.7; p≤0.001). Conclusion: PCV13 vaccination has significantly reduced the incidence of pneumococcal meningitis, which presents most severely, with early neurological complications in 41.5% of cases, cerebral edema in 90.9% of infants, and hypertensive syndrome in 81.8%. Early diagnosis and timely treatment contribute to the prevention of both early and late neurological complications. Актуальность: Бактериальные менингиты (БМ) остаются значимой причиной неврологических осложнений и высокой смертности среди детей. Цель исследования: изучение клинических особенностей БМ у детей для оптимизации диагностики и этиопатогенетической терапии. Методы: Объект исследования - дети с диагнозом "менингит", пролеченные в Многопрофильной городской детской больнице №3 в г.Астана, за период с 2015 по 2023 гг. Дизайн исследования: проспективный, контроль – случай. Методы включали клинический осмотр, общий анализ крови, анализ спинномозговой жидкости, КТ и МРТ головного мозга. Для статистической обработки использовались описательная статистика и метод Пирсона. Результаты: Введение вакцины ПКВ13 привело к четырехкратному снижению заболеваемости пневмококковым менингитом, в то время как случаи менингококкового менингита уменьшились в 1,6 раз с 2014 по 2023 годы. Основные клинические проявления у детей с БМ включали высокую температуру (80-90% пациентов, с фебрильной температурой от 38,7°С до 39,9°С), неврологические дефициты и осложнения: судороги и когнитивные нарушения–развивались у 50% детей. Гипертензионный синдром наблюдали в 81,8 % случаях в группе детей с ПМ, в 55,6% случаях при ММ у детей до 1 года. Пневмококковое поражение ЦНС характеризовалось развитием очаговой симптоматики в 45,5% случаев у детей раннего возраста, при ММ данные изменения зарегистрированы статистически достоверно меньше в 3 раза (16,7% р≤0,001). Корреляционный анализ по методу Спирмена в группе детей с ПМ продемонстрировала сильную прямую положительную связь между показателями: поздней обращаемости и количеством койко-дней (r=0,7;р≤0,001), поздней диагностикой и количеством койко-дней (r=0,7;р≤0,001). Заключение: Вакцинация ПКВ13 привела к значительному снижению заболеваемости пневмококковым менингитом, который протекает наиболее тяжелее с ранними неврологическими осложнениями в 41,5% случаев, отеком головного мозга у детей первого года жизни в 90,9%, гипертензионным синдромом в 81,8%. Ранняя диагностика и своевременное лечение способствуют предотвращению ранних и поздних неврологических осложнений. Өзектілігі: Бактериялық...

23 October 2026 in Astana Medical Journal
Verified
Journal Article
Closed access
GZGalina Zhumagaliyeva
Galina Zhumagaliyeva
BTBayan Turdalina
Bayan Turdalina
ABAigerim Baiguliyeva
Aigerim Baiguliyeva
YAYerkezhan Adiletova
Yerkezhan Adiletova
GYGulzhan Yesimkhanova
Gulzhan Yesimkhanova
DBDinagul Bayesheva
Dinagul Bayesheva
Acute gastroenteritis (AGE) remains one of the leading causes of infectious morbidity among children. The aim of this study was to conduct a comprehensive analysis of epidemiological trends, limitations of laboratory diagnostics, and antimicrobial resistance patterns of AGE pathogens among children in Kazakhstan during 2018–2025. A retrospective analysis of official statistical data, clinical and laboratory indicators, and microbiological study results from 2018 to 2025 was performed. Trends in bacterial and viral AGE, age-specific disease distribution, the impact of the COVID-19 pandemic, and antimicrobial resistance profiles of clinically significant enterobacteria were evaluated. A decline in the incidence of bacterial AGE, including shigellosis and salmonellosis, was identified, accompanied by an increase in cases of unspecified etiology. The highest involvement in the epidemic process of viral diarrheal diseases was observed among children under 14 years of age. Significant fluctuations in incidence rates were recorded during the post-pandemic period. The COVID-19 pandemic affected the epidemiology of intestinal infections and was associated with gastrointestinal manifestations in children. Analysis of antimicrobial resistance among opportunistic enterobacteria (Klebsiella pneumoniae, Proteus mirabilis, ESBL-producing Escherichia Coli, and Pseudomonas aeruginosa) demonstrated high levels of resistance to ampicillin and third-generation cephalosporins. Limitations in laboratory diagnostics and epidemiological surveillance were identified, related to the low proportion of etiologically confirmed cases and inadequate registration of viral diarrheal diseases. Acute gastroenteritis in children remains a significant public health concern in Kazakhstan. Improvement of laboratory diagnostics through the implementation of molecular genetic methods, strengthening epidemiological surveillance of bacterial and viral intestinal infections, and expanding antimicrobial resistance monitoring are necessary to enhance treatment effectiveness and prevent complications. Keywords: acute gastroenterocolitis, children, intestinal infections, diarrhea, antibiotic resistance.